MONTREAL (CP) -- Revenue Canada is seeking $2 billion from pharmaceutical giant Merck Frosst in unpaid taxes, a newspaper report suggests.
Sources said that the federal department sent a notice to the company the first week of October. It is seeking taxes on a portion of the global profits from its popular drug Singulair.
The asthma treatment was developed in Montreal. But Merck transferred a part of its profits from the drug to Barbados.
Merck Frosst is one of the most important pharmaceutical companies in Canada. It employs 1,600 workers, including 1,100 in Montreal.